These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23522498)

  • 1. Clinical and immunological follow-up of B-cell depleting therapy in CNS demyelinating diseases.
    Gredler V; Mader S; Schanda K; Hegen H; Di Pauli F; Kuenz B; Deisenhammer F; Berger T; Reindl M; Lutterotti A
    J Neurol Sci; 2013 May; 328(1-2):77-82. PubMed ID: 23522498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient increases in anti-aquaporin-4 antibody titers following rituximab treatment in neuromyelitis optica, in association with elevated serum BAFF levels.
    Nakashima I; Takahashi T; Cree BA; Kim HJ; Suzuki C; Genain CP; Vincent T; Fujihara K; Itoyama Y; Bar-Or A
    J Clin Neurosci; 2011 Jul; 18(7):997-8. PubMed ID: 21565508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders.
    Banwell B; Tenembaum S; Lennon VA; Ursell E; Kennedy J; Bar-Or A; Weinshenker BG; Lucchinetti CF; Pittock SJ
    Neurology; 2008 Jan; 70(5):344-52. PubMed ID: 18094334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct features between longitudinally extensive transverse myelitis presenting with and without anti-aquaporin 4 antibodies.
    Chang KH; Lyu RK; Chen CM; Wu YR; Chang HS; Huang CC; Kuo HC; Chu CC; Hsu WC; Ro LS
    Mult Scler; 2013 Mar; 19(3):299-307. PubMed ID: 22829325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease.
    Lechner C; Baumann M; Hennes EM; Schanda K; Marquard K; Karenfort M; Leiz S; Pohl D; Venkateswaran S; Pritsch M; Koch J; Schimmel M; Häusler M; Klein A; Blaschek A; Thiels C; Lücke T; Gruber-Sedlmayr U; Kornek B; Hahn A; Leypoldt F; Sandrieser T; Gallwitz H; Stoffels J; Korenke C; Reindl M; Rostásy K
    J Neurol Neurosurg Psychiatry; 2016 Aug; 87(8):897-905. PubMed ID: 26645082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab.
    Pellkofer HL; Krumbholz M; Berthele A; Hemmer B; Gerdes LA; Havla J; Bittner R; Canis M; Meinl E; Hohlfeld R; Kuempfel T
    Neurology; 2011 Apr; 76(15):1310-5. PubMed ID: 21482945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of longitudinally extensive transverse myelitis (LETM): neuromyelitis optica.
    Mangat P; Ravindran J; Cleland L; Limaye V
    Clin Rheumatol; 2008 Dec; 27 Suppl 2():S67-9. PubMed ID: 18560921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis.
    Waters P; Jarius S; Littleton E; Leite MI; Jacob S; Gray B; Geraldes R; Vale T; Jacob A; Palace J; Maxwell S; Beeson D; Vincent A
    Arch Neurol; 2008 Jul; 65(7):913-9. PubMed ID: 18625857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromyelitis optica and pregnancy during therapeutic B cell depletion: infant exposure to anti-AQP4 antibody and prevention of rebound relapses with low-dose rituximab postpartum.
    Ringelstein M; Harmel J; Distelmaier F; Ingwersen J; Menge T; Hellwig K; Kieseier B; Mayatepek E; Hartung HP; Kuempfel T; Aktas O
    Mult Scler; 2013 Oct; 19(11):1544-7. PubMed ID: 23886825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinally extensive transverse myelitis immune-mediated in aquaporin-4 antibody negative patients: Disease heterogeneity.
    Carnero Contentti E; Hryb JP; Morales S; Gomez A; Chiganer E; Di Pace JL; Lessa C; Perassolo M
    J Neurol Sci; 2017 Feb; 373():134-137. PubMed ID: 28131170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients.
    Fazio R; Malosio ML; Lampasona V; De Feo D; Privitera D; Marnetto F; Centonze D; Ghezzi A; Comi G; Furlan R; Martino G
    Mult Scler; 2009 Oct; 15(10):1153-63. PubMed ID: 19667009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
    Kitley J; Woodhall M; Waters P; Leite MI; Devenney E; Craig J; Palace J; Vincent A
    Neurology; 2012 Sep; 79(12):1273-7. PubMed ID: 22914827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromyelitis optica IgG status in acute partial transverse myelitis.
    Scott TF; Kassab SL; Pittock SJ
    Arch Neurol; 2006 Oct; 63(10):1398-400. PubMed ID: 17030654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody to aquaporin-4 in the long-term course of neuromyelitis optica.
    Jarius S; Aboul-Enein F; Waters P; Kuenz B; Hauser A; Berger T; Lang W; Reindl M; Vincent A; Kristoferitsch W
    Brain; 2008 Nov; 131(Pt 11):3072-80. PubMed ID: 18945724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinally extensive transverse myelitis.
    Tobin WO; Weinshenker BG; Lucchinetti CF
    Curr Opin Neurol; 2014 Jun; 27(3):279-89. PubMed ID: 24792338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders.
    Jarius S; Jacobi C; de Seze J; Zephir H; Paul F; Franciotta D; Rommer P; Mader S; Kleiter I; Reindl M; Akman-Demir G; Seifert-Held T; Kristoferitsch W; Melms A; Wandinger KP; Wildemann B
    Mult Scler; 2011 Sep; 17(9):1067-73. PubMed ID: 21543553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic aquaporin-4 antibody negative longitudinally extensive transverse myelitis.
    Hyun JW; Kim SH; Huh SY; Kim W; Yun J; Joung A; Sato DK; Fujihara K; Kim HJ
    Mult Scler; 2015 May; 21(6):710-7. PubMed ID: 25305252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aquaporin-4 antibody positive longitudinally extensive transverse myelitis following varicella zoster infection.
    Heerlein K; Jarius S; Jacobi C; Rohde S; Storch-Hagenlocher B; Wildemann B
    J Neurol Sci; 2009 Jan; 276(1-2):184-6. PubMed ID: 18805556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuromyelitis optica.
    Matiello M; Jacob A; Wingerchuk DM; Weinshenker BG
    Curr Opin Neurol; 2007 Jun; 20(3):255-60. PubMed ID: 17495617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.
    Hinson SR; McKeon A; Fryer JP; Apiwattanakul M; Lennon VA; Pittock SJ
    Arch Neurol; 2009 Sep; 66(9):1164-7. PubMed ID: 19752309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.